Cubic Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.27M | Sell |
23,493
-200
| -0.8% | -$20.5K | 0.54% | 54 |
|
|
2023
Q4 | $2.39M | Sell |
23,693
-2,100
| -8% | -$203K | 0.61% | 47 |
|
|
2023
Q3 | $2.63M | Sell |
25,793
-3,155
| -11% | -$320K | 0.72% | 43 |
|
|
2023
Q2 | $2.92M | Sell |
28,948
-1,810
| -6% | -$181K | 0.79% | 41 |
|
|
2023
Q1 | $2.83M | Sell |
30,758
-850
| -3% | -$74.2K | 0.79% | 40 |
|
|
2022
Q4 | $2.87M | Sell |
31,608
-2,185
| -6% | -$184K | 0.82% | 40 |
|
|
2022
Q3 | $2.57M | Sell |
33,793
-100
| -0.3% | -$8.29K | 0.76% | 43 |
|
|
2022
Q2 | $2.87M | Sell |
33,893
-100
| -0.3% | -$8.77K | 0.77% | 46 |
|
|
2022
Q1 | $2.98M | Sell |
33,993
-100
| -0.3% | -$8.66K | 0.69% | 50 |
|
|
2021
Q4 | $2.98M | Hold |
34,093
| – | – | 0.68% | 50 |
|
|
2021
Q3 | $2.79M | Hold |
34,093
| – | – | 0.69% | 50 |
|
|
2021
Q2 | $3.11M | Sell |
34,093
-275
| -0.8% | -$24.5K | 0.77% | 45 |
|
|
2021
Q1 | $2.94M | Sell |
34,368
-725
| -2% | -$65.1K | 0.78% | 46 |
|
|
2020
Q4 | $3.31M | Buy |
35,093
+610
| +2% | +$53.3K | 0.98% | 37 |
|
|
2020
Q3 | $3M | Sell |
34,483
-610
| -2% | -$52.8K | 1.08% | 36 |
|
|
2020
Q2 | $3.06M | Sell |
35,093
-135
| -0.4% | -$11.7K | 1.1% | 35 |
|
|
2020
Q1 | $2.9M | Sell |
35,228
-575
| -2% | -$51.3K | 1.17% | 32 |
|
|
2019
Q4 | $3.39M | Sell |
35,803
-1,120
| -3% | -$100K | 0.96% | 37 |
|
|
2019
Q3 | $3.21M | Sell |
36,923
-90
| -0.2% | -$8.08K | 0.96% | 40 |
|
|
2019
Q2 | $3.38M | Sell |
37,013
-4,483
| -11% | -$379K | 1.01% | 39 |
|
|
2019
Q1 | $3.58M | Sell |
41,496
-2,176
| -5% | -$175K | 1.06% | 36 |
|
|
2018
Q4 | $3.36M | Sell |
43,672
-929
| -2% | -$72.3K | 1.1% | 35 |
|
|
2018
Q3 | $3.44M | Sell |
44,601
-112
| -0.3% | -$8.28K | 0.94% | 40 |
|
|
2018
Q2 | $3.03M | Sell |
44,713
-1,953
| -4% | -$135K | 0.87% | 45 |
|
|
2018
Q1 | $3.38M | Sell |
46,666
-42
| -0.1% | -$3.2K | 0.96% | 38 |
|
|
2017
Q4 | $3.51M | Sell |
46,708
-1,269
| -3% | -$95.7K | 0.98% | 37 |
|
|
2017
Q3 | $3.69M | Sell |
47,977
-669
| -1% | -$50.5K | 1.04% | 34 |
|
|
2017
Q2 | $3.64M | Sell |
48,646
-1,535
| -3% | -$109K | 1.06% | 33 |
|
|
2017
Q1 | $3.34M | Sell |
50,181
-84
| -0.2% | -$5.6K | 1.02% | 35 |
|
|
2016
Q4 | $3.28M | Hold |
50,265
| – | – | 1.01% | 36 |
|
|
2016
Q3 | $3.56M | Sell |
50,265
-407
| -0.8% | -$29.7K | 1.15% | 32 |
|
|
2016
Q2 | $3.75M | Sell |
50,672
-781
| -2% | -$54K | 1.27% | 26 |
|
|
2016
Q1 | $3.34M | Sell |
51,453
-2,020
| -4% | -$137K | 1.12% | 34 |
|
|
2015
Q4 | $4.12M | Hold |
53,473
| – | – | 1.43% | 27 |
|
|
2015
Q3 | $4.4M | Sell |
53,473
-173
| -0.3% | -$15.4K | 1.56% | 16 |
|
|
2015
Q2 | $4.73M | Sell |
53,646
-999
| -2% | -$91.6K | 1.51% | 20 |
|
|
2015
Q1 | $4.83M | Sell |
54,645
-3,432
| -6% | -$304K | 1.55% | 20 |
|
|
2014
Q4 | $4.82M | Sell |
58,077
-139
| -0.2% | -$11.5K | 1.56% | 22 |
|
|
2014
Q3 | $4.91M | Sell |
58,216
-223
| -0.4% | -$18K | 1.72% | 17 |
|
|
2014
Q2 | $4.74M | Sell |
58,439
-782
| -1% | -$61.5K | 1.56% | 15 |
|
|
2014
Q1 | $4.51M | Sell |
59,221
-585
| -1% | -$42.6K | 1.55% | 18 |
|
|
2013
Q4 | $4.31M | Sell |
59,806
-84
| -0.1% | -$5.84K | 1.35% | 19 |
|
|
2013
Q3 | $4.12M | Sell |
59,890
-84
| -0.1% | -$5.56K | 1.34% | 21 |
|
|
2013
Q2 | $3.8M | Buy |
+59,974
| New | +$3.9M | 1.31% | 26 |
|
Other funds holding NVS
Cubic Asset Management's NVS Position: Q1 2024 in Review
Cubic Asset Management reduced its Novartis (NVS) stake by 0.84% in Q1 2024, selling an estimated $20.5K and leaving 23,493 shares worth $2.27M. The position accounts for 0.54% of the portfolio, ranked #54.
Cubic Asset Management first reported a position in NVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.91M in Q3 2014. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.
- Cubic Asset Management held 23,493 shares of Novartis worth $2.27M as of Q1 2024.
- Cubic Asset Management sold 200 Novartis shares in Q1 2024, an estimated $20.5K.
- Novartis made up 0.54% of Cubic Asset Management's portfolio in Q1 2024, its #54 holding.
- Cubic Asset Management first reported a position in Novartis in Q2 2013 and has held it in 44 quarters since.
- Cubic Asset Management's Novartis position peaked at $4.91M in Q3 2014.
- 1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.
Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.